EMERGENT BIOSOLUTIONS INC. Share Repurchase Authorization
EMERGENT BIOSOLUTIONS INC. (EBS) had Share Repurchase Authorization of $250.00 million as of 2021-11-11, per its 10-K filed 2024-03-08.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramAuthorizedAmount1 · last filed 2024-03-08
- 2021-11-11: Stock Repurchase Program, Authorized Amount $250.00M.
- 2016-07-14: Stock Repurchase Program, Authorized Amount $50.00M.
| Period end | Stock Repurchase Program, Authorized Amount |
|---|---|
| 2021-11-11 | $250.00M 10-K · filed 2024-03-08 |
| 2016-07-14 | $50.00M 10-K · filed 2018-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |